Systematic Review of Pediatric Abdominal Aortic Aneurysms.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 42526669.
- Also identified by DOI 10.1016/j.jvs.2026.06.178.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pediatric abdominal aortic aneurysms (AAAs) are rare and differ fundamentally from adult degenerative disease in etiology, presentation, and management. We performed a systematic review to characterize the causes, clinical features, treatment strategies, and outcomes of pediatric AAAs. A PRISMA-compliant systematic review was conducted using PubMed/MEDLINE, Embase, and Web of Science from inception through March 2025. Studies reporting AAAs in patients ≤18 years were included. Case reports and case series were eligible. Data extracted included demographics, aneurysm characteristics, etiology, presentation, management approach, complications, and outcomes. Seventy-seven studies encompassing 87 pediatric patients met inclusion criteria. The median age at presentation was 13 months [IQR: 1-96 months], with some cases identified in the prenatal period. Etiologies were idiopathic congenital (50.6%), mycotic (26.4%), genetic disorders (17.2%), and vasculitis (5.7%). Nearly half of aneurysms were detected incidentally, including 8 identified prenatally. Thirteen patients (15%) presented with rupture. Most aneurysms were infrarenal (81.6%), with a mean diameter of 4.6 cm. Open surgical repair was the predominant treatment (74 patients), most commonly using prosthetic grafts. Overall mortality was 17.2%, with deaths primarily associated with rupture or postoperative complications. Survival was favorable in non-ruptured patients undergoing repair. Pediatric AAAs represent a heterogeneous and clinically significant entity distinct from adult disease. Early recognition in high-risk populations and timely surgical intervention are critical. Given the absence of pediatric-specific guidelines, multicenter collaboration and long-term surveillance data are needed to inform evidence-based management strategies.